Marco Graffino

Learn More
BACKGROUND Antipsychotic medications are the key of the treatment in schizophrenia, and a large body of data confirms the value of ongoing and continuous antipsychotic pharmacotherapy in controlling symptoms and preventing relapse. Even so medication non-adherence in patients with schizophrenia continues to be a significant problem and threatens successful(More)
AIM To investigate the relationships among psychopatology, cognitive functioning, quality of life and competitive employment in patients with stable schizophrenia. MATERIALS AND METHODS We recruited 143 consecutive outpatients with stable schizophrenia, divided into 2 groups (unemployed and competitive employed subjects). A clinical and a(More)
  • 1